AstraZeneca: all 4,196 studies
Page 6 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With BenralizumabCompletedNCT04159519Phase 4Results posted
- Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.Active, not recruitingNCT04157348Phase 3Results posted
- Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)TerminatedNCT04157335Phase 3Results posted
- A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum DisorderTerminatedNCT04155424Phase 2/3Results posted
- An Open-label, Phase II Study of AZD4635 in Patients With Prostate CancerCompletedNCT04089553Phase 2Results posted
- Durvalumab Long-Term Safety and Efficacy StudyCompletedNCT04078152Phase 4Results posted
- Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.CompletedNCT04078126Phase 3Results posted
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4041 in Healthy VolunteersCompletedNCT04076540Phase 1Results posted
- Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic LeukemiaActive, not recruitingNCT04075292Phase 3Results posted
- COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRCActive, not recruitingNCT04068610Phase 1/2Results posted
- Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe AsthmaCompletedNCT04048343Phase 3Results posted
- Tezepelumab COPD Exacerbation StudyCompletedNCT04039113Phase 2Results posted
- A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)Active, not recruitingNCT04035486Phase 3Results posted
- A Study to Assess the Relative Bioavailability of 3 Different Formulations Under Fasted and Fed ConditionCompletedNCT04024501Phase 1Results posted
- A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH.CompletedNCT04019561Phase 2Results posted
- Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia PatientsCompletedNCT04008706Phase 3Results posted
- A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and HyperuricaemiaCompletedNCT03990363Phase 2Results posted
- A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY)CompletedNCT03979313Phase 3Results posted
- Tezepelumab Home Use StudyCompletedNCT03968978Phase 3Results posted
- Investigate the Influence of Severe Hepatic Impairment on the Pharmacokinetics of Acalabrutinib and Its MetaboliteCompletedNCT03968848Phase 1Results posted
- Open-label Extension Study of Brazikumab in Crohn's DiseaseTerminatedNCT03961815Phase 3Results posted
- A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk ChildrenCompletedNCT03959488Phase 2/3Results posted
- Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell MalignanciesActive, not recruitingNCT03932331Phase 1/2Results posted
- Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled AsthmaCompletedNCT03927157Phase 3Results posted
- An Exploratory Study to Characterise Changes in Airway Inflammation, Symptoms, Lung Function and Reliever Use in Adult Asthma PatientsCompletedNCT03924635Phase 4Results posted
- Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia GravisCompletedNCT03920293Phase 3Results posted
- A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers.CompletedNCT03907969Phase 1/2Results posted
- DETERMINE-reduced - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Reduced Ejection FractionCompletedNCT03877237Phase 3Results posted
- DETERMINE-preserved - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection FractionCompletedNCT03877224Phase 3Results posted
- Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)Active, not recruitingNCT03875235Phase 3Results posted
- Osimertinib Study in Indian PatientsCompletedNCT03853551Phase 4Results posted
- Durvalumab and Tremelimumab for Pediatric MalignanciesActive, not recruitingNCT03837899Phase 1/2Results posted
- A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPDCompletedNCT03836677Phase 3Results posted
- Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)CompletedNCT03830866Phase 3Results posted
- Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLCCompletedNCT03822351Phase 2Results posted
- Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung CancerCompletedNCT03794544Phase 2Results posted
- Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior OsimertinibActive, not recruitingNCT03778229Phase 2Results posted
- Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)Active, not recruitingNCT03775486Phase 2Results posted
- A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449CompletedNCT03766399Phase 1Results posted
- A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)CompletedNCT03759366Phase 3Results posted
- An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's DiseaseTerminatedNCT03759288Phase 2/3Results posted
- Safety and Tolerability Study of AZD4831 in Patients With Heart Failure.TerminatedNCT03756285Phase 2Results posted
- Efficacy and Safety of MEDI7352 in Participants With Painful Diabetic NeuropathyTerminatedNCT03755934Phase 2Results posted
- Ravulizumab Subcutaneous (SC) Versus Ravulizumab Intravenous (IV) in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With EculizumabCompletedNCT03748823Phase 3Results posted
- A Study to Evaluate the Safety and Tolerability of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes MellitusCompletedNCT03745937Phase 2Results posted
- A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast CancerActive, not recruitingNCT03742102Phase 1/2Results posted
- Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer PatientsActive, not recruitingNCT03737643Phase 3Results posted
- Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate CancerActive, not recruitingNCT03732820Phase 3Results posted
- Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBCActive, not recruitingNCT03732677Phase 3Results posted
- A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer PatientsActive, not recruitingNCT03706690Phase 3Results posted
- Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled AsthmaCompletedNCT03706079Phase 3Results posted
- Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation TherapyActive, not recruitingNCT03703297Phase 3Results posted
- A Study to Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung CancerCompletedNCT03693300Phase 2Results posted
- Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)CompletedNCT03688074Phase 2Results posted
- Trial of Andexanet Alfa in ICrH Patients Receiving an Oral FXa InhibitorCompletedNCT03661528Phase 4Results posted
- A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases.CompletedNCT03645434Phase 2Results posted
- Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 DiabetesCompletedNCT03645421Phase 2Results posted
- A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic SubjectsCompletedNCT03622112Phase 2Results posted
- Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.CompletedNCT03619213Phase 3Results posted
- Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative ColitisTerminatedNCT03616821Phase 2Results posted
- Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell DiseaseTerminatedNCT03615924Phase 3Results posted
- MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.CompletedNCT03611556Phase 1/2Results posted
- A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes MellitusCompletedNCT03596177Phase 2Results posted
- A Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial InfarctionCompletedNCT03578809Phase 2Results posted
- Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 2 of 4)CompletedNCT03578146Phase 2Results posted
- D2560C00015 FluMist Annual Safety Study 2018CompletedNCT03564444Phase 4Results posted
- Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe AsthmaCompletedNCT03557307Phase 3Results posted
- A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.CompletedNCT03555994Phase 2Results posted
- A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal UlcerCompletedNCT03553563Phase 3Results posted
- Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 4 of 4)CompletedNCT03551743Phase 2Results posted
- Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4)CompletedNCT03551730Phase 2Results posted
- A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well ToleratedCompletedNCT03550378Phase 2Results posted
- Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum ChemotherapyCompletedNCT03534453Phase 3Results posted
- Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart FailureTerminatedNCT03532009Phase 2Results posted
- A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.CompletedNCT03528681Phase 3Results posted
- A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)Active, not recruitingNCT03521154Phase 3Results posted
- Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung CancerCompletedNCT03519971Phase 3Results posted
- Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Response to EculizumabCompletedNCT03472885Phase 2Results posted
- Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain MetastasesCompletedNCT03463525Phase 1Results posted
- A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)Active, not recruitingNCT03459846Phase 2Results posted
- A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471TerminatedNCT03459443Phase 2Results posted
- Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 DiabetesCompletedNCT03444584Phase 2Results posted
- A Study of Ravulizumab (ALXN1210) in Children and Adolescents With Paroxysmal Nocturnal HemoglobinuriaCompletedNCT03406507Phase 3Results posted
- Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent AsthmaCompletedNCT03406078Phase 3Results posted
- Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Participants With Wilson DiseaseTerminatedNCT03403205Phase 3Results posted
- Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer PatientsCompletedNCT03402841Phase 3Results posted
- Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal PolyposisCompletedNCT03401229Phase 3Results posted
- A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work, Heart Nutrient Uptake, and Heart Muscle Efficiency in Type 2 Diabetes PatientsCompletedNCT03387683Phase 4Results posted
- Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination StudyActive, not recruitingNCT03381274Phase 1/2Results posted
- Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With AsthmaCompletedNCT03371459Phase 2Results posted
- AZD8601 Study in CABG PatientsCompletedNCT03370887Phase 2Results posted
- A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G)CompletedNCT03369236Phase 2Results posted
- Early Phase Study to Assess Efficacy and Safety of AZD9567 Versus Prednisolone in Patients With Rheumatoid ArthritisCompletedNCT03368235Phase 2Results posted
- Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With AsthmaCompletedNCT03364608Phase 2Results posted
- Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant AsthmaCompletedNCT03358147Phase 2/3Results posted
- THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and DeathCompletedNCT03354429Phase 3Results posted
- A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart DiseaseCompletedNCT03351738Phase 2Results posted
- Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled AsthmaCompletedNCT03347279Phase 3Results posted
- Study Evaluating Betrixaban in Pediatric ParticipantsTerminatedNCT03346083Phase 1Results posted
- Effects of 5 Weeks Treatment With Dapagliflozin in Type 2 Diabetes Patients on How the Hormone Insulin Acts on Sugar Uptake in Muscles.CompletedNCT03338855Phase 4Results posted